Blog
Checkpoint inhibitor completes preclinical investigation
Regen BioPharma Press Release Feb 24, 2016: Regen BioPharma, Inc., announced today the completion of experiments, in collaboration with PNI Neuro-oncologist and JWCI researcher, Dr. Santosh Kesari, demonstrating immunological mechanisms of its novel NR2F6 gene silencing approach. The Company has begun the process of compiling an...
Adapting to a Chronic Condition
by Guest Writer Dr. Patti Johnson It takes Two – You and Your Support Team A chronic condition is one that persists over time without an easily definable beginning, middle and end. After being diagnosed with a chronic condition, such as some types of brain...
Last updated: November 13th, 2019